- Report
- April 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,107GBP
- Report
- April 2023
- 156 Pages
Global
€4804EUR$5,000USD£4,107GBP
- Report
- April 2023
- 114 Pages
Global
€3363EUR$3,500USD£2,875GBP
- Report
- April 2023
- 109 Pages
Global
€3363EUR$3,500USD£2,875GBP
- Report
- February 2020
- 207 Pages
Global
From €5160EUR$5,370USD£4,411GBP
- Report
- March 2023
- 147 Pages
Global
From €5764EUR$5,999USD£4,928GBP
Ventolin is a brand of albuterol, a bronchodilator drug used to treat and prevent symptoms of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). It is a fast-acting drug that works by relaxing the muscles in the airways, allowing more air to flow in and out of the lungs. It is available in both inhaler and nebulizer forms, and is often prescribed as a rescue medication for acute asthma attacks.
The Ventolin market is a subset of the larger respiratory drugs market, which includes a variety of medications used to treat and prevent respiratory diseases. These drugs are used by a wide range of patients, from children to adults, and are often prescribed in combination with other medications. The market is highly competitive, with many different companies offering similar products.
Some of the companies in the Ventolin market include GlaxoSmithKline, AstraZeneca, Merck, Novartis, and Boehringer Ingelheim. Show Less Read more